drugset / Trial / NCT00742508
A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the safety and tolerability of SK\&F-105517-D in japanese patients with chronic heart failure.
Timeline
- Start
- 2008-08-28
- Primary completion
- 2009-08-21
- Completion
- 2009-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 2.5 mg | — |
| Subject | Carvedilol | Other / unclassified | 10 mg | — |
| Subject | SK&F-105517-D | Unknown | 10 mg | — |
| Subject | SK&F-105517-D | Unknown | 20 mg | — |
| Subject | SK&F-105517-D | Unknown | 40 mg | — |